Tempest Therapeutics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
Tempest Therapeutics, Inc. (TPST) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 497.54 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-08-13
- Tempest Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-06-30 was 50.00K shares, a 64835.06% increase year-over-year.
- Tempest Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-03-31 was 447.54K shares, a 244.23% increase year-over-year.
- Tempest Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-12-31 was -77.00 shares, a 110.59% decline year-over-year.
- Tempest Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-09-30 was 0.00 shares, a 100.00% decline year-over-year.
- Tempest Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 130.01K shares, a 88.40% increase from fiscal 2024.
- Tempest Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 69.01K shares, a 97.01% decline from fiscal 2023.
- Tempest Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 2.31M shares, a 153.85% increase from fiscal 2022.
- Tempest Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 909.53K shares, a 195.75% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 1 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 50.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | 497.54K shares 10-Q · filed 2026-08-13 | 497.46K shares derived: sum of 3 quarters · filed 2026-08-13 | 497.46K shares derived: sum of 4 quarters · filed 2026-08-13 | |||||
| 2026-03-31 | 447.54K shares 10-Q · filed 2026-05-14 | 447.46K shares derived: sum of 2 quarters · filed 2026-05-14 | 447.46K shares derived: sum of 3 quarters · filed 2026-05-14 | 447.54K shares derived: sum of 4 quarters · filed 2026-08-13 | |||||
| 2025-12-31 | -77.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -77.00 shares derived: sum of 2 quarters · filed 2026-03-30 | 0.00 shares derived: sum of 3 quarters · filed 2026-08-13 | 130.01K shares 10-K · filed 2026-03-30 | |||||
| 2025-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | 77.00 shares derived: sum of 2 quarters · filed 2026-08-13 | 130.09K shares 10-Q · filed 2025-11-05 | 130.82K shares derived: sum of 4 quarters · filed 2026-08-13 | |||||
| 2025-06-30 | 77.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | 130.09K shares 10-Q · filed 2026-08-13 | 130.82K shares derived: sum of 3 quarters · filed 2026-08-13 | 141.55K shares derived: sum of 4 quarters · filed 2026-08-13 | |||||
| 2025-03-31 | 130.01K shares 10-Q · filed 2026-05-14 | 130.09K shares 10-Q · filed 2025-05-13 | 130.74K shares derived: sum of 2 quarters · filed 2026-05-14 | 141.47K shares derived: sum of 3 quarters · filed 2026-05-14 | 147.89K shares derived: sum of 4 quarters · filed 2026-05-14 | ||||
| 2024-12-31 | 727.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | 11.46K shares derived: sum of 2 quarters · filed 2026-03-30 | 17.87K shares derived: sum of 3 quarters · filed 2026-03-30 | 69.01K shares 10-K · filed 2026-03-30 | 897.13K shares 10-K · filed 2025-03-27 | ||||
| 2024-09-30 | 10.73K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | 17.15K shares derived: sum of 2 quarters · filed 2025-11-05 | 68.28K shares 10-Q · filed 2025-11-05 | 887.67K shares 10-Q · filed 2024-11-12 | 1.70M shares derived: sum of 4 quarters · filed 2025-11-05 | ||||
| 2024-06-30 | 6.42K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | 57.55K shares 10-Q · filed 2025-08-11 | 748.17K shares 10-Q · filed 2024-08-08 | 1.69M shares derived: sum of 3 quarters · filed 2025-08-11 | 1.69M shares derived: sum of 4 quarters · filed 2025-08-11 | ||||
| 2024-03-31 | 51.14K shares 10-Q · filed 2025-05-13 | 664.77K shares 10-Q · filed 2024-05-09 | 1.68M shares derived: sum of 2 quarters · filed 2025-05-13 | 1.68M shares derived: sum of 3 quarters · filed 2025-05-13 | 1.74M shares derived: sum of 4 quarters · filed 2025-05-13 | ||||
| 2023-12-31 | 1.63M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | 1.63M shares derived: sum of 2 quarters · filed 2025-03-27 | 1.69M shares derived: sum of 3 quarters · filed 2025-03-27 | 2.31M shares 10-K · filed 2025-03-27 | |||||
| 2023-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | 55.60K shares derived: sum of 2 quarters · filed 2024-11-12 | 679.15K shares 10-Q · filed 2024-11-12 | 685.15K shares derived: sum of 4 quarters · filed 2024-11-12 | |||||
| 2023-06-30 | 55.60K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | 679.15K shares 10-Q · filed 2024-08-08 | 685.15K shares derived: sum of 3 quarters · filed 2024-08-08 | 695.15K shares derived: sum of 4 quarters · filed 2024-08-08 | |||||
| 2023-03-31 | 623.55K shares 10-Q · filed 2024-05-09 | 629.55K shares derived: sum of 2 quarters · filed 2024-05-09 | 639.55K shares derived: sum of 3 quarters · filed 2024-05-09 | 1.23M shares derived: sum of 4 quarters · filed 2024-05-09 | |||||
| 2022-12-31 | 6.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | 16.00K shares derived: sum of 2 quarters · filed 2024-03-19 | 606.40K shares derived: sum of 3 quarters · filed 2024-03-19 | 909.53K shares 10-K · filed 2024-03-19 | |||||
| 2022-09-30 | 10.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | 600.40K shares derived: sum of 2 quarters · filed 2023-11-08 | 903.53K shares 10-Q · filed 2023-11-08 | 978.39K shares derived: sum of 4 quarters · filed 2023-11-08 | |||||
| 2022-06-30 | 590.40K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | 893.53K shares 10-Q · filed 2023-08-10 | 968.39K shares derived: sum of 3 quarters · filed 2023-08-10 | 1.01M shares derived: sum of 4 quarters · filed 2023-08-10 | |||||
| 2022-03-31 | 303.13K shares 10-Q · filed 2023-05-10 | 377.99K shares derived: sum of 2 quarters · filed 2023-05-10 | 424.17K shares derived: sum of 3 quarters · filed 2023-05-10 | 548.19K shares derived: sum of 4 quarters · filed 2023-05-10 | |||||
| 2021-12-31 | 74.86K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | 121.05K shares derived: sum of 2 quarters · filed 2023-03-22 | 245.06K shares derived: sum of 3 quarters · filed 2023-03-22 | 307.53K shares 10-K · filed 2023-03-22 | |||||
| 2021-09-30 | 46.19K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | 170.20K shares derived: sum of 2 quarters · filed 2022-11-08 | 232.67K shares 10-Q · filed 2022-11-08 | -1.37M shares derived: sum of 4 quarters · filed 2022-11-08 | |||||
| 2021-06-30 | 124.01K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | 186.48K shares 10-Q · filed 2022-08-15 | -1.41M shares derived: sum of 3 quarters · filed 2022-08-15 | -1.41M shares derived: sum of 4 quarters · filed 2022-08-15 | |||||
| 2021-03-31 | 62.47K shares 10-Q · filed 2022-05-13 | 534.00K shares 10-Q · filed 2021-05-13 | -1.54M shares derived: sum of 2 quarters · filed 2022-05-13 | -1.54M shares derived: sum of 3 quarters · filed 2022-05-13 | -570.92K shares derived: sum of 4 quarters · filed 2022-05-13 | ||||
| 2020-12-31 | -1.60M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | -1.60M shares derived: sum of 2 quarters · filed 2022-03-29 | -633.38K shares derived: sum of 3 quarters · filed 2022-03-29 | 224.49K shares 10-K · filed 2022-03-29 | 1.86M shares 10-K · filed 2021-03-29 | ||||
| 2020-09-30 | 750.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | 966.50K shares derived: sum of 2 quarters · filed 2020-11-09 | 1.82M shares 10-Q · filed 2020-11-09 | 1.86M shares derived: sum of 4 quarters · filed 2021-03-29 | |||||
| 2020-06-30 | 965.75K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | 1.82M shares 10-Q · filed 2020-08-10 | 1.86M shares derived: sum of 3 quarters · filed 2021-03-29 | 2.02M shares derived: sum of 4 quarters · filed 2021-03-29 | |||||
| 2020-05-31 | 840.45K shares 10-Q · filed 2021-05-13 | ||||||||
| 2020-03-31 | 857.88K shares 10-Q · filed 2020-05-08 | 893.27K shares derived: sum of 2 quarters · filed 2021-03-29 | 1.06M shares derived: sum of 3 quarters · filed 2021-03-29 | 1.38M shares derived: sum of 4 quarters · filed 2021-03-29 | |||||
| 2019-12-31 | 35.40K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | 197.20K shares derived: sum of 2 quarters · filed 2021-03-29 | 520.77K shares derived: sum of 3 quarters · filed 2021-03-29 | 1.23M shares 10-K · filed 2021-03-29 | |||||
| 2019-09-30 | 161.80K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | 485.37K shares derived: sum of 2 quarters · filed 2019-11-13 | 1.19M shares 10-Q · filed 2019-11-13 | 1.34M shares derived: sum of 4 quarters · filed 2020-05-08 | |||||
| 2019-06-30 | 323.57K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-12 | 1.03M shares 10-Q · filed 2019-08-12 | 1.18M shares derived: sum of 3 quarters · filed 2020-05-08 | 1.80M shares derived: sum of 4 quarters · filed 2020-05-08 | |||||
| 2019-03-31 | 705.13K shares 10-Q · filed 2020-05-08 | 851.55K shares derived: sum of 2 quarters · filed 2020-05-08 | 1.48M shares derived: sum of 3 quarters · filed 2020-05-08 | 1.48M shares derived: sum of 4 quarters · filed 2020-05-08 | |||||
| 2018-12-31 | 146.42K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-11 | 776.14K shares derived: sum of 2 quarters · filed 2020-03-11 | 776.14K shares derived: sum of 3 quarters · filed 2020-03-11 | 776.14K shares 10-K · filed 2020-03-11 | |||||
| 2018-09-30 | 629.72K shares 10-Q · filed 2019-11-13 | 72.00K shares 10-Q · filed 2018-11-09 | 629.72K shares derived: sum of 2 quarters · filed 2019-11-13 | 629.72K shares 10-Q · filed 2019-11-13 | 1.25M shares 10-Q · filed 2018-11-09 | -3.58M shares derived: sum of 4 quarters · filed 2019-11-13 | |||
| 2018-06-30 | 0.00 shares 10-Q · filed 2019-08-12 | 1.18M shares 10-Q · filed 2018-08-09 | 0.00 shares 10-Q · filed 2019-08-12 | -4.21M shares derived: sum of 3 quarters · filed 2019-08-12 | -4.02M shares derived: sum of 4 quarters · filed 2019-08-12 | ||||
| 2018-03-31 | 0.00 shares 10-Q · filed 2019-05-15 | 1.18M shares 10-Q · filed 2018-05-03 | -4.21M shares derived: sum of 2 quarters · filed 2019-05-15 | -4.02M shares derived: sum of 3 quarters · filed 2019-05-15 | -1.83M shares derived: sum of 4 quarters · filed 2019-05-15 | ||||
| 2017-12-31 | -4.21M shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | -4.02M shares derived: sum of 2 quarters · filed 2019-04-01 | -1.83M shares derived: sum of 3 quarters · filed 2019-04-01 | 0.00 shares 10-K · filed 2019-04-01 | 4.39M shares 10-K · filed 2018-03-15 | ||||
| 2017-09-30 | 192.50K shares 10-Q · filed 2018-11-09 | 2.38M shares derived: sum of 2 quarters · filed 2018-11-09 | 4.21M shares 10-Q · filed 2018-11-09 | 4.56M shares derived: sum of 4 quarters · filed 2018-11-09 | |||||
| 2017-06-30 | 2.18M shares 10-Q · filed 2018-08-09 | 4.02M shares 10-Q · filed 2018-08-09 | 4.37M shares derived: sum of 3 quarters · filed 2018-08-09 | 5.11M shares derived: sum of 4 quarters · filed 2018-08-09 | |||||
| 2017-03-31 | 1.83M shares 10-Q · filed 2018-05-03 | 2.19M shares derived: sum of 2 quarters · filed 2018-05-03 | 2.93M shares derived: sum of 3 quarters · filed 2018-05-03 | 3.37M shares derived: sum of 4 quarters · filed 2018-05-03 | |||||
| 2016-12-31 | 356.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-02 | 1.09M shares derived: sum of 2 quarters · filed 2017-11-02 | 1.54M shares derived: sum of 3 quarters · filed 2017-11-02 | 2.58M shares 10-K · filed 2017-03-02 | |||||
| 2016-09-30 | 737.50K shares 10-Q · filed 2017-11-02 | 1.18M shares derived: sum of 2 quarters · filed 2017-11-02 | 2.22M shares 10-Q · filed 2017-11-02 | ||||||
| 2016-06-30 | 446.45K shares 10-Q · filed 2017-08-03 | 1.49M shares 10-Q · filed 2017-08-03 | |||||||
| 2016-03-31 | 1.03M shares 10-Q · filed 2017-05-09 | ||||||||
| 2015-12-31 | 1.80M shares 10-K · filed 2016-02-26 | ||||||||
| 2014-09-30 | 1.50M shares 10-Q · filed 2014-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B |